...uality at beaches along the Great Lakes have promp...safe for recreation. A new collaborative project i...s when they are faced with deciding whether to clo...ative effort will draw on the expertise of U.S. Ge... agencies. , The project has been funded through...
...able in Spanish . , , Breaking up the dosage of...ces the quality of wheat and limits its negative e...of the PhD thesis of University of the Basque Coun..., presented at the Faculty of Science and Technolo...des, more concretely during the second half of the...
...ATE RELEASE , New-generation artificial cornea c...chnology Progress , An improved artificial corne...million people worldwide who are blind due to dise...ientists in California conclude in a new analysis ... for the June 6 issue of ACS, Biotechnology Progre...
Other Biology News:To swim or not to swim? 2Dosage of fertilizer helps to enhance quality of wheat 2Dosage of fertilizer helps to enhance quality of wheat 3American Chemical Society's Weekly PressPac -- May 14, 2008 2American Chemical Society's Weekly PressPac -- May 14, 2008 3American Chemical Society's Weekly PressPac -- May 14, 2008 4American Chemical Society's Weekly PressPac -- May 14, 2008 5American Chemical Society's Weekly PressPac -- May 14, 2008 6American Chemical Society's Weekly PressPac -- May 14, 2008 7American Chemical Society's Weekly PressPac -- May 14, 2008 8(Date:11/9/2009)... The Appignani Bioethics...ation, held a panel discussion today at the Nation...chnologies in biomedical sciences and climate chan...Andrew Light, both of the Center for American Prog...olitical angles. ,, A video of the event will ...
(Date:11/9/2009)...9 /PRNewswire-Asia/ -- The pharma and biotech sect...e companies are facing significant,pressure to cha...costs, calls for,lower prices and a greater regula...nancial crisis have made the work of creating new ...es are being forced to globalize their R&D,ope...
(Date:11/9/2009)...r 9 Following the provision of cli...Administration (FDA), privately,owned UK company D...national.com ) has been informed that its innovati...rded an Orphan-Drug,designation for the treatment ... ALS, also known as Lou Gehrig,s disease, is the m...
(Date:11/6/2009).... 6 BioSpecifics Technol...company developing first-in-class collagenase-base...for the third quarter ended September 30, 2009. ,...f this year, the FDA,s Arthritis Advisory Committe...approval of XIAFLEX(TM) for the treatment of Dupuy...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6..., VANCOUVER, Feb. 9 /PRNewswire-FirstCall/ - iCo T...ce the completion of a $1,292,500 non-brokered pri...y with sufficient capital to develop iCo-007 throu.... iCo-007 is targeting the treatment of Diabetic M...e company with additional working capital. iCo,s p...
..., ST. LOUIS, Feb. 9 Solutia Inc. (NYSE: SOA... president and CEO, will address,investors at the ... p.m.,Eastern time on Wednesday, February 11, 2009...ion and a replay will be available on the investor...o: http://www.newscom.com/cgi-bin/prnh/20081029/...
..., CALGARY, Feb. 9 /PRNewswire/ - Orcrist Bio Inc. ...izing pharmaceuticals, announced today that it has...ville, Spain, a Phase I, open-label, single-ascend...olunteers. The goal of the study is to assess the ...odynamics (induction of hematopoiesis) of HYC750, ...
Other Biology Technology:iCo Therapeutics Closes $1.3 Million Private Placement 2iCo Therapeutics Closes $1.3 Million Private Placement 3Solutia to Present at Deutsche Bank Small and Mid Cap Conference 2Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 2Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 3...Capture high-resolution chemiluminescent and biolu...em. High-sensitivity camera is cooled to subzero t...e dynamic range for high quality images in a short...ptimum conditions for chemiluminescence and includ...
...nucleotide) Genome Set and MEEBO (Mouse Exonic Evi... collection of open source oligo probes, largely d...ng interrogation of thousands of genes. Developed ...ord University and UCSF, the sets enable the study...
Rabbit Anti-FANCE Polyclonal Antibody, Unconjugated from Abcam
Alu I from New England Biolabs
Biology Products: